[HTML][HTML] Berberine in non-alcoholic fatty liver disease—A review
A Koperska, A Wesołek, M Moszak, M Szulińska - Nutrients, 2022 - mdpi.com
The incidence of Non-Alcoholic Fatty Liver Disease (NAFLD) has been rapidly increasing
during the last decade. It is a relevant health problem that affects 25% of the general …
during the last decade. It is a relevant health problem that affects 25% of the general …
Update on berberine in nonalcoholic fatty liver disease
Y Liu, L Zhang, H Song, G Ji - … ‐Based Complementary and …, 2013 - Wiley Online Library
Berberine (BBR), an active ingredient from nature plants, has demonstrated multiple
biological activities and pharmacological effects in a series of metabolic diseases including …
biological activities and pharmacological effects in a series of metabolic diseases including …
[HTML][HTML] Preclinical evidence of berberine on non-alcoholic fatty liver disease: a systematic review and meta-analysis of animal studies
S Ren, X Ma, R Wang, H Liu, Y Wei, S Wei… - Frontiers in …, 2021 - frontiersin.org
As lifestyle and diet structure impact our health, non-alcoholic fatty liver disease (NAFLD) is
prevalent all over the world. Some phytomedicines containing berberine (BBR) have been …
prevalent all over the world. Some phytomedicines containing berberine (BBR) have been …
[HTML][HTML] The potential mechanisms of berberine in the treatment of nonalcoholic fatty liver disease
X Zhu, H Bian, X Gao - Molecules, 2016 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is a globally observed metabolic disease with high
prevalence both in adults and children. However, there is no efficient medication available …
prevalence both in adults and children. However, there is no efficient medication available …
[HTML][HTML] The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Q Nie, M Li, C Huang, Y Yuan, Q Liang, X Ma… - Journal of Translational …, 2024 - Springer
Background Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent
worldwide, emerging as a significant health issue on a global scale. Berberine exhibits …
worldwide, emerging as a significant health issue on a global scale. Berberine exhibits …
[HTML][HTML] Efficacy of berberine in patients with non-alcoholic fatty liver disease
HM Yan, MF Xia, Y Wang, XX Chang, XZ Yao, SX Rao… - PloS one, 2015 - journals.plos.org
Objectives A randomized, parallel controlled, open-label clinical trial was conducted to
evaluate the effect of a botanic compound berberine (BBR) on NAFLD. Methods A …
evaluate the effect of a botanic compound berberine (BBR) on NAFLD. Methods A …
[HTML][HTML] Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut …
S Yang, S Cao, C Li, J Zhang, C Liu, F Qiu… - Frontiers in …, 2022 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is a major public health problem in many
countries. Berberine (BBR) is an effective therapeutic agent in alleviating NAFLD …
countries. Berberine (BBR) is an effective therapeutic agent in alleviating NAFLD …
[HTML][HTML] Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
Background Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic
manifestation of metabolic syndrome. Berberine (BBR) exerts anti-hyperglycemic and anti …
manifestation of metabolic syndrome. Berberine (BBR) exerts anti-hyperglycemic and anti …
The therapeutic effect of berberine in the treatment of nonalcoholic fatty liver disease: A meta‐analysis
X Wei, C Wang, S Hao, H Song… - … and Alternative Medicine, 2016 - Wiley Online Library
Aim. To assess the efficacy of berberine in the treatment of nonalcoholic fatty liver disease
through meta‐analysis. Method. We searched Embase, Pubmed, Cochrane Library, and so …
through meta‐analysis. Method. We searched Embase, Pubmed, Cochrane Library, and so …
[HTML][HTML] Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress
The histological spectrum of nonalcoholic fatty liver diseases (NAFLD) ranges from hepatic
steatosis to steatohepatitis and fibrosis. Berberine (BBR) is known for its therapeutic effect …
steatosis to steatohepatitis and fibrosis. Berberine (BBR) is known for its therapeutic effect …